Transcatheter tricuspid valve interventions offer promising less-invasive alternatives with early results and sustained benefits for high-risk patients with severe tricuspid regurgitation.
Do transcatheter tricuspid valve interventions improve safety and effectiveness in patients with severe tricuspid regurgitation?
Transcatheter tricuspid valve interventions provide a promising, less-invasive alternative for high-risk patients with severe tricuspid regurgitation, demonstrating safety and efficacy in early clinical data.
Tricuspid regurgitation (TR) is a common valvular heart disease that is associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities and risks, especially for high-risk patients, with in-hospital mortality rates of ˜9%. This resulted in the undertreatment of many patients with TR, creating a substantial unmet need. This has stimulated the development of transcatheter techniques, such as transcatheter tricuspid valve replacement, tricuspid edge-to-edge repair, tricuspid annuloplasty, caval valve implantation and many others, which offer less-i nvasive alternatives with promising early results and sustained benefits. This review provides a contemporary outlook on different transcatheter tricuspid valve interventions in patients with severe TR and assesses the existing clinical data regarding the safety and effectiveness of these devices in a rapidly expanding space.
Sammour et al. (Thu,) conducted a review in Tricuspid regurgitation. Transcatheter tricuspid valve interventions was evaluated. Transcatheter tricuspid valve interventions offer promising less-invasive alternatives with early results and sustained benefits for high-risk patients with severe tricuspid regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: